Pulmonary hypertension is a rare lung disorder in which the arteries that carry blood from the heart to the lungs become narrow, making it difficult for blood to flow through the vessels. As a result, the blood pressure in pulmonary arteries rises above normal levels. This abnormally high pressure strains the right ventricle of the heart which could lead to the development of right heart failure. One of the medicines for the treatment of this disease is phosphodiesterase5 (PDE5) inhibitors such as sildenefil (viagra ® ). In the preliminary study, we found that curcuminoid analogs could inhibit PDE5 in a significant level. In this study, we aim at the study of the effect of curcumin (AS-KI 020) and its analogs; AS-KI 021, 022, 033, 064, 086, 087, and 098 on the relaxation of pulmonary artery. The pulmonary arteries with endothelium were isolated from wistar rats and tested in an organ bath using MacLab for monitoring the relaxation. The result showed that curcumin and analogs had EC 50 values in the range of 10 -5 M. Interestingly, these compounds did not affect aorta. The result of maximum relaxation with and without endothelium suggested that the action targets are both smooth muscle and endothelial cells. The evidence from the study supports the development of the curcuminoid analogs for therapeutic application on pulmonary hypertension.
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